Research Portfolio

We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.

If you are interested in a specific research program area, browse the recently funded research by program area.

To browse active grants you may also wish to view the current Grants Portfolio publication.

Filter for Grant pages

Research Program Area
Disease:
Breed:
Grant Status:
One Health:
 

Keyword Search for Grant pages


Search Results

 Title

 Institution

Investigator

Status

Research Program Area

02992-A: Sentinel Lymph Node Mapping for Dogs with Lung Tumors University of Guelph Michelle Oblak, DVM, DVSc Open Oncology
03032-MOU: Early Detection of Canine Osteosarcoma University of Minnesota Jamie Modiano, VMD, PhD Open Oncology - Osteosarcoma
03019: Evaluation of a Targeted Anti αvβ3 Integrin Near-InfraRed (NIR-) Dye for Controlled Resection of Naturally Occurring Soft Tissue Sarcomas in Dogs University of Zurich Mirja Nolff, Dr. med. vet., DVM Open Oncology - Osteosarcoma, Oncology
03009: Evaluating Accuracy for Identification of Sentinel Lymph Nodes in Dogs with Cutaneous MCT: A Comparison University of Florida Judith Bertran, DVM, MS and Natalie Worden, DVM Open Oncology
03003: Suppression of Extracellular Glutamate Efflux & mGluR1 Signaling to Impede Canine Hemangiosarcoma Cell Growth University of Illinois Timothy Fan, DVM, PhD Open Oncology - Hemangiosarcoma
02998: Whole-Exome and Transcriptome Sequencing of Canine Small Cell B Cell Lymphoma and Comparative Analysis to Diffuse Large B Cell Lymphoma Colorado State University Anne Avery, DVM, PhD Open Oncology - Lymphoma
03000: Characterizing the Immunomodulatory Response of Histotripsy in Canine Osteosarcoma Virginia-Maryland Regional College of Veterinary Medicine Joanne Tuohy, DVM, PhD Open Oncology - Osteosarcoma
03017: Molecular Characterization of Canine Soft Tissue Sarcomas Using Spatially Defined Proteomics and Transcriptomics University of Zurich Enni Markkanen, Dr. med. vet., Dr. sc. nat. Open Oncology
03011: A GD3 Nano-scaled Liposomal Cancer Vaccine Clinical Trial for Canine Hemangiosarcoma University of Florida Rowan Milner, BVSc, MMedVet, PhD, Keijiro Shiomitsu, DVM, and Sandra Bechtel, DVM Open Oncology - Hemangiosarcoma
02999: Evaluating Magnetic Resonance Imaging for Quantifying Histotripsy Ablation in Canine Osteosarcoma Virginia-Maryland Regional College of Veterinary Medicine Joanne Tuohy, DVM, PhD Open Oncology - Osteosarcoma
02991-A: Investigating Extracellular Crosstalk Between Canine Osteosarcoma and Macrophages North Carolina State University Erika Gruber, DVM, PhD Open Oncology - Osteosarcoma
03015: The Immune and Molecular Landscape of Canine Osteosarcoma at the Single-Cell Level University of Minnesota Jaime F Modiano, VMD, PhD Open Oncology - Osteosarcoma
03007: Chimeric BiTE-redirected Anti-viral T Cells for Fratricide of Minimal Residual Disease in T-cell Malignancies North Carolina State University Paul Hess, DVM, PhD Open Oncology - Lymphoma
02987: It’s All In The Genes: The Mutational Landscape of Acute Myeloid Leukemia in Dogs Cornell University Tracy Stokol, BVSc, PhD Open Blood Disorders, Oncology
02946: Towards Curative Outcomes in Canine Hemangiosarcoma Ethos Discovery Chand Khanna, DVM, PhD Open Oncology - Hemangiosarcoma
02942: Genome-wide Molecular Interrogation of Canine Hemangiosarcoma Cornell University Scott Coonrod, PhD Open Oncology - Hemangiosarcoma
02912: Adoptive Natural Killer (NK) Cell Immunotherapy for Canine Lymphoma The Ohio State University William Kisseberth, DVM, PhD Open Oncology - Lymphoma
02907: Ultrasound-guided Histotripsy Ablation of Canine Brain Tumors through an Acoustically Transparent Cranial Window Virginia-Maryland Regional College of Veterinary Medicine John Rossmeisl, DVM, MS Open Oncology
02880: Enhanced Surgical Margin Imaging with Polarization-sensitive Optical Coherence Tomography in Canine Soft Tissue Sarcoma and Mammary Tumors The Ohio State University Laura Selmic, BVetMed, MPH Open Oncology
02910: Open-Label, Phase-2 Clinical Trial of Chlorambucil and Toceranib for Canine Mast Cell Tumors Colorado State University Kristen Weishaar, DVM, MS Open Oncology
02879: Use of CRISPR-based Genome-wide Approach for Identification of Vulnerabilities in Canine Oral Melanoma R(D)SVS and Roslin Institute, University of Edinburgh Maciej Parys, DVM, PhD Open Oncology
02890: Characterizing the LINE-1 Transcriptome in Canine High-grade Peripheral T-cell Lymphoma by RNAseq to Gain Insight into Mechanisms of Drug and Immune Resistance North Carolina State University Paul Hess, DVM, PhD Open Oncology - Lymphoma
02885: Exposure to Environmental Chemicals in Boxers with Lymphoma University of Wisconsin, Madison Lauren Trepanier, DVM, PhD Open Oncology - Lymphoma
02855-A: Repurposing Drugs to Modulate Myeloid-derived Suppressor Cells (MDSCs) in Canine Soft Tissue Sarcomas Louisiana State University Sita Withers, BVSc, PhD Open Oncology
02858-A: Investigation of Mechanisms of Resistance to Immunotherapy in Dogs with Spontaneous High-grade Glioma University of Minnesota Susan Arnold, DVM Open Oncology
02920: Continued Investigation into Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes University of Pennsylvania Susan W. Volk, VMD, PhD Open Oncology
02864-A: Luteinizing Hormone Receptor Activation in Canine Hemangiosarcoma Cells Oregon State University Michelle Kutzler, DVM, PhD Open Oncology - Hemangiosarcoma
02806-MOU: Strategic Prevention of Canine Hemangiosarcoma: Lifetime Follow-Up University of Minnesota Jaime F Modiano, VMD PhD Open Oncology - Hemangiosarcoma
02759: Reprogramming the Tumor Immune Niche in Canine Hemangiosarcoma University of Minnesota Jong Hyuk Kim, DVM, PhD Open Oncology - Hemangiosarcoma
02768: Defining the Functional Consequences and Therapeutic Vulnerability of Dystrophin Alterations in Canine Osteosarcoma Tufts University Cheryl A. London, DVM, PhD Open Oncology - Osteosarcoma
02758: Optical Coherence Tomography for Margin Evaluation of Canine Skin and Subcutaneous Neoplasms The Ohio State University Laura Selmic, BVetMed, MPH Open Oncology
02780: Bladder Carcinogen Exposures in Pet Dogs University of Wisconsin, Madison Lauren Trepanier, DVM, PhD Open Oncology
02746-A: Evaluation of Serum miRNA as a Diagnostic Tool for Canine Splenic Hemangiosarcoma University of Georgia Janet Grimes, DVM, MS Open Oncology - Hemangiosarcoma
02773: Histotripsy for Treatment of Canine Appendicular Osteosarcoma Virginia-Maryland Regional College of Veterinary Medicine Joanne Tuohy, DVM, PhD Open Oncology - Osteosarcoma
02782: Genetic Contribution to Early-onset Osteosarcoma University of Wisconsin, Madison Susannah Sample, DVM, MS, PhD Open Oncology - Osteosarcoma
02772: Identifying Early Stage Ultra-rare Mutations as Predictive Biomarkers of Lymphoma in High-risk versus Low-risk Breeds Within the Dog Aging Project University of Washington Daniel Promislow, PhD Open Oncology - Lymphoma
02783: Transcriptional Profiling of Canine Soft Tissue Sarcoma Cornell University Andrew D. Miller, DVM Open Oncology
02739-A: The Role of the Putative Tumor Suppressor Gene SETD2 in Canine Diffuse Large B-cell Lymphoma Michigan State University Bonnie Harrington, DVM, PhD Open Oncology - Lymphoma
02732-A: Tumor-educated Platelets: A Novel Minimally Invasive Liquid Biopsy for Early Cancer Diagnosis Texas A&M AgriLife Research Unity Jeffery, VetMB, PhD Open Oncology
02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma University of Minnesota Erin B. Dickerson, PhD and Antonella Borgatti, DVM, MS Open Oncology - Hemangiosarcoma
02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD Open Oncology
02502: Precision Medicine for Canine Lymphoma Trustees of the University of Pennsylvania Nicola J Mason, BVetMed, PhD Open Oncology - Lymphoma
02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma Tufts University School of Medicine Cheryl A. London, DVM, PhD Open Oncology - Hemangiosarcoma
02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs Colorado State University Steven W. Dow, DVM, PhD Open Oncology
02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma University of Pennsylvania Nicola J Mason, BVetMed, PhD Open Oncology
02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations North Carolina State University Edward B Breitschwerdt, DVM; Matthew Breen, PhD Open Tick-Borne Disease Initiative , Oncology - Hemangiosarcoma
02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma University of Missouri Angela McCleary-Wheeler, DVM, PhD Open Oncology - Lymphoma
01660: Identifying the Genes That Confer Risk for Osteosarcoma The Research Institute at Nationwide Children's Hospital Carlos E. Alvarez, PhD Open Oncology - Osteosarcoma

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

   2020 GuideStar logo

© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.